53.30000 USD
1.4
2.56%
Last update Dec 15, 3:59 PM EST
Market closed
Day range
52.0099983
54.13000
Previous close
54.70000
Open
54.0099983
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
53.30
1.40
2.56%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 11.8M 11.2M 10.5M 29.2M
Cost of revenue 0 0 0 8.0M
Gross profit 11.8M 11.2M 10.5M 21.2M
Operating expense
Research & development 27.3M 29.9M 30.5M 28.7M
Selling general and admin 16.1M 17.1M 24.3M 17.1M
Other operating expenses
Operating income -31.5M -35.8M -44.4M -24.7M
Non operating interest income
Income 2.8M 2.0M 2.9M 2.9M
Expense 6.0M 5.4M 5.0M 10.2M
Other income expense -261K -187K 97K 38.9M
Pretax income -35.0M -39.4M -46.4M 7.0M
Tax provision -33K -188K 52K -259K
Net income -35.5M -41.6M -50.9M 7.3M
Basic EPS -1.9 -3.0 -3.6 0.5
Diluted EPS -1.9 -3.0 -3.6 0.5
Basic average shares 18.9M 14.1M 14.1M 14.0M
Diluted average shares 18.9M 14.1M 14.1M 14.2M
EBITDA -28.6M -33.3M -40.8M -21.5M
Net income from continuing op. -35.5M -41.6M -50.9M 7.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 6 hours 46 minutes

21:13
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).